Tiziana Life Sciences (TLSA)
(Delayed Data from NSDQ)
$1.11 USD
+0.04 (3.40%)
Updated Sep 19, 2024 03:59 PM ET
After-Market: $1.04 -0.07 (-6.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
TLSA 1.11 +0.04(3.40%)
Will TLSA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TLSA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TLSA
Buy Tesla Stock for Humanoid Robots and Full-Self Driving?
TLSA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TLSA
Tiziana Life Sciences announces $4M grant awarded by NIH to study Anti-CD3
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer?s Disease
Tesla's upcoming robotaxi event has analysts and investors guessing
Tiziana Life Sciences Welcomes New CEO
Tiziana Life Sciences appoints Elrifi as CEO